BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 677139)

  • 1. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of cephalosporins therapy in therapeutic practice of 15 Italian hospitals (author's transl)].
    Martini N; Bozzini L
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():406-18. PubMed ID: 555525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of education on cephalosporin prescribing patterns.
    Frye CB; Baker B; Sexton DJ; Dougherty FK
    J Okla State Med Assoc; 1987 Sep; 80(9):649-53. PubMed ID: 3668708
    [No Abstract]   [Full Text] [Related]  

  • 10. Influencing drug use through prescribing restrictions.
    Huber SL; Patry RA; Hudson HD
    Am J Hosp Pharm; 1982 Nov; 39(11):1898-901. PubMed ID: 6128922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use, misuse, and cost of parenteral cephalosporins at a county hospital.
    Appleby DH; John JF
    South Med J; 1980 Nov; 73(11):1473-5. PubMed ID: 7444511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulary evaluation of third-generation cephalosporins using decision analysis.
    Cano SB; Fujita NK
    Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy and therapeutics committee review of the parenteral cephalosporins.
    Phelps MR; Godwin HN
    Am J Hosp Pharm; 1978 Jan; 35(1):73-5. PubMed ID: 623122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implications.
    Petros WP; Shank WA
    Hosp Pharm; 1986 Jul; 21(7):648-9, 654-6. PubMed ID: 10311603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible savings with appropriate antibiotic prophylaxis.
    Hodgson T; Lannigan R; Mills D
    Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.